Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 1,040

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo

Hughes, David E., Wright, Kenneth R., Uy, Harry L., Sasaki, Akira, Yoneda, Toshiyuki, Roodman, David G., Mundy, Gregory R., Dr. Boyce, Brendan F.·1995·Journal of Bone and Mineral Research

Abstract

Bisphosphonates inhibit bone resorption and are therapeutically effective in diseases of increased bone turnover, such as Paget's disease and hypercalcemia of malignancy. The mechanisms by which they act remain unclear. Proposed mechanisms include inhibition of osteoclast formation from precursors and inhibitory or toxic effects on mature osteoclasts. We have developed a new in vitro model to study osteoclast survival and in this paper present in vitro and in vivo evidence that may explain both the observed reduction in osteoclast numbers and in bone resorption by mature osteoclasts, namely that bisphosphonates induce programmed cell death (apoptosis). Three bisphosphonates (risedronate, pamidronate, and clodronate) caused a 4- to 24-fold increase in the proportion of osteoclasts showing the characteristic morphology of apoptosis in vitro. This observation was confirmed in vivo in normal mice, in mice with increased bone resorption, and in nude mice with osteolytic cancer metastases, with similar-fold increases to those observed in vitro. Of the three compounds, risedronate, the most potent inhibitor of bone resorption in vivo, was the strongest inducer of osteoclast apoptosis in vitro. Osteoclast apoptosis may therefore be a major mechanism whereby bisphosphonates reduce osteoclast numbers and activity, and induction of apoptosis could be a therapeutic goal for new antiosteoclast drugs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/jbmr.5650101008

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Research works printed but not linked: 50

  1. Fleisch, 1991, Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemia and metastatic bone disease, Drugs, 42, 919, 10.2165/00003495-199142060-00003 · DOI · Paper page
  2. Fleisch, 1993, Prospective use of bisphosphonates in osteoporosis, J Clin Endocrinol Metab, 76, 1397
  3. Altman, 1973, Influence of sodium etidronate on clinical and laboratory manifestations of Paget's disease of bone (osteitis deformans), New Engl J Med, 289, 1379, 10.1056/NEJM197312272892601 · DOI · Paper page
  4. Russell, 1974, Diphosphonates in Paget's disease, Lancet, i, 894
  5. Storm, 1990, Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis, New Engl J Med, 322, 1265, 10.1056/NEJM199005033221803 · DOI · Paper page
  6. Fleisch, 1982, Bone and Mineral Research Annual 1, 319
  7. Hughes, 1991, The cellular mechanism of action of bisphosphonates, Drugs Exp Clin Res, 17, 109
  8. Wyllie, 1980, Cell death: The significance of apoptosis, Int Rev Cytol, 68, 251, 10.1016/S0074-7696(08)62312-8 · DOI · Paper page
  9. Williams, 1993, Molecular regulation of apoptosis: Genetic controls on cell death, Cell, 74, 777, 10.1016/0092-8674(93)90457-2 · DOI · Paper page
  10. Fuller, 1993, Macrophage colony-stimulating factor stimulates survival and chemotactic behavior in isolated osteoclasts, J Exp Med, 178, 1733, 10.1084/jem.178.5.1733 · DOI · Paper page
  11. Minkin, 1982, Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function, Calcif Tissue Int, 34, 285, 10.1007/BF02411252 · DOI · Paper page
  12. Takahashi, 1988, Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures, Endocrinology, 122, 1473, 10.1210/endo-122-4-1373 · DOI · Paper page
  13. Takahashi, 1988, Induction of calcitonin receptors by 1,25-dihydroxyvitamin D3 in osteoclast-like multinucleated cells formed from mouse bone marrow cells, Endocrinology, 123, 1504, 10.1210/endo-123-3-1504 · DOI · Paper page
  14. Sasaki, 1989, Multinucleated cells formed on calcified dentine from mouse bone marrow cells treated with 1,25-dihydroxyvitamin D3 have ruffled borders and resorb bone, Anat Rec, 224, 379, 10.1002/ar.1092240307 · doi:10.1002/ar.1092240307
  15. Arends, 1993, Susceptibility to apoptosis is differentially regulated by c-myc and mutated Ha-ras oncogenes and is associated with endonuclease availability, Br J Cancer, 68, 1127, 10.1038/bjc.1993.492 · DOI
  16. Fouda, 1989, Developmental disturbances of the rat molar induced by two diphosphonates, Adv Dent Res, 3, 234, 10.1177/08959374890030022401 · doi:10.1177/08959374890030022401
  17. Sietsema, 1989, Antiresorptive dose-response relationships across three generations of bisphosphonates, Drugs Exp Clin Res, 15, 389
  18. Stutzer, 2088 Short- and long-term effects of a single dose of bisphosphonates on retinoid-induced bone resorption in thyroparathyroidectomized rats, Calcif Tissue Int, 43, 294, 10.1007/BF02556639 · DOI
  19. Uy, 1994, Risedronate affects mature osteoclasts (ocl) but not ocl precursors in vivo, J Bone Miner Res, 9, S242
  20. Boyce, 1989, Effects of interleukin-1 on bone turnover in normal mice, Endocrinology, 125, 1142, 10.1210/endo-125-3-1142 · DOI · Paper page
  21. Boyce, 1992, Requirement of pp60c-src expression for osteoclasts to form ruffled borders and resorb bone in mice, J Clin Invest, 90, 1623, 10.1172/JCI116032 · DOI · Paper page
  22. Arguello, 1988, A murine model of experimental metastasis to bone and bone marrow, Cancer Res, 48, 6876
  23. Nakai, 1992, A synthetic antagonist to laminin inhibits the formation of osteolytic metastases by human melanoma cells in nude mice, Cancer Res, 52, 5395
  24. Gavrieli, 1992, Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation, J Cell Biol, 119, 493, 10.1083/jcb.119.3.493 · DOI · Paper page
  25. Wyllie, 1980, Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation, Nature, 284, 555, 10.1038/284555a0 · DOI · Paper page
  26. Boonekamp, 1986, Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix, Bone Miner, 1, 27
  27. Hughes, 1989, Inhibition of osteoclast-like cell formation by bisphosphonates in long-term cultures of human bone marrow, J Clin Invest, 83, 1930, 10.1172/JCI114100 · DOI · Paper page
  28. Lerner, 1987, Effects of four bisphosphonates on bone resorption, lysosomal enzyme release, protein synthesis and mitotic activities in mouse calvarial bones in vitro, Bone, 8, 179, 10.1016/8756-3282(87)90018-4 · DOI
  29. Flanagan, 1989, Dichloromethylene bisphosphonate (Cl2MBP) inhibits bone resorption through injury to osteoclasts that resorb Cl2MBP-coated bone, Bone Miner, 6, 33, 10.1016/0169-6009(89)90021-4 · DOI · Paper page
  30. Sato, 1990, Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy, J Bone Miner Res, 5, 31, 10.1002/jbmr.5650050107 · DOI · Paper page
  31. Pioli, 1990, Bisphosphonates stimulate the production of cytokines by human peripheral blood mononuclear cells in vitro, Calcif Tissue Int, 46, A54
  32. Johnson, 1989, Tumors producing human tumor necrosis factor induce hypercalcemia and osteoclastic bone resorption in nude mice, Endocrinology, 124, 1424, 10.1210/endo-124-3-1424 · DOI
  33. Yoshiki, 1990, IL-6 is produced by osteoblasts and induces bone resorption, J Immunol, 145, 3297, 10.4049/jimmunol.145.10.3297 · DOI · Paper page
  34. Bursch, 1990, Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats, Carcinogenesis, 11, 847, 10.1093/carcin/11.5.847 · DOI · Paper page
  35. Jung, 1973, The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals, Calcif Tissue Res, 11, 269, 10.1007/BF02547227 · DOI · Paper page
  36. Sahni, 1993, Bisphosphonates act on rat bone resorption through the mediation of osteoblasts, J Clin Invest, 91, 2004, 10.1172/JCI116422 · DOI · Paper page
  37. Stevenson, 1986, Cytotoxic and migration inhibitory effects of bisphosphonates on macrophages, Calcif Tissue Int, 38, 227, 10.1007/BF02556715 · DOI
  38. Cecchini, 1987, Effect of bisphosphonates on proliferation and viability of mouse bone marrow-derived macrophages, J Bone Miner Res, 2, 135, 10.1002/jbmr.5650020209 · DOI
  39. Cecchini, 1990, Bisphosphonates in vitro specifically inhibit, among the hematopoietic series, the development of the mouse mononuclear phagocyte lineage, J Bone Miner Res, 5, 1019, 10.1002/jbmr.5650051005 · DOI
  40. Chambers, 1980, Diphosphonates inhibit bone resorption by macrophages in vitro, J Pathol, 132, 255, 10.1002/path.1711320307 · DOI
  41. Reitsma, 1982, Differential actions of the bisphosphonates APD and CL2MDP on macrophage-mediated bone resorption in vitro, J Clin Invest, 70, 927, 10.1172/JCI110704 · DOI
  42. Sarih, 1993, Nitric oxide synthase induces macrophage death by apoptosis, Biochem Biophys Res Commun, 191, 503, 10.1006/bbrc.1993.1246 · DOI · Paper page
  43. Zanovello, 1990, Responses of mouse lymphocytes to extracellular ATP. II. Extracellular ATP causes cell type-dependent lysis and DNA fragmentation, J Immunol, 145, 1545, 10.4049/jimmunol.145.5.1545 · DOI · Paper page
  44. Rotello, 1991, Coordinated regulation of apoptosis and cell proliferation by transforming growth factor βl in cultured uterine epithelial cells, Proc Natl Acad Sci USA, 88, 3412, 10.1073/pnas.88.8.3412 · DOI · Paper page
  45. Lotem, 1992, Hematopoietic cytokines inhibit apoptosis induced by transforming growth factor βl and cancer chemotherapy compounds in myeloid leukemic cells, Blood, 80, 1750, 10.1182/blood.V80.7.1750.bloodjournal8071750 · doi:10.1182/blood.v80.7.1750.bloodjournal8071750
  46. Bursch, 1993, Transforming growth factor-βl as a signal for induction of cell death by apoptosis, Br J Cancer, 67, 531, 10.1038/bjc.1993.98 · DOI
  47. Suda, 1994, Purification and characterization of the Fas-ligand that induces apoptosis, J Exp Med, 179, 873, 10.1084/jem.179.3.873 · DOI · Paper page
  48. Seyedin, 1986, Cartilage-inducing factor-A; apparent identity to transforming growth factor-β, J Biol Chem, 261, 5693, 10.1016/S0021-9258(17)38436-3 · DOI · Paper page
  49. Hughes, 1994, TGFβ1 induces osteoclast apoptosis in vitro, J Bone Miner Res, 9, S138
  50. Schenck, 1973, Effect of ethane-1-hydroxy-1.1-diphosphonate (EHDP) and dichloromethylene diphosphonate (CL2MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats, Calcif Tissue Res, 11, 196, 10.1007/BF02547219 · DOI · Paper page

Cited by

See all 1,040

Metadata

Authors
Hughes, D. E., Wright, K. R., Uy, H. L., Sasaki, A., Yoneda, T., Roodman, D. G., Mundy, G. R., & Dr. Boyce, B. F.
Venue
Journal of Bone and Mineral Research
Published
1995-10-01
Volume
10
Issue
10
Pages
1478-1487
ISSN
  • 0884-0431 (ISSN-L)
  • 1523-4681
OpenAlex
W2161690532
Cited by
1,040
References
2
FWCI
10.54
Type
journal article
Language
en
Open access
closed
Funders
  • NIH (DE 08569, CA 40035, AR-41336)
  • American Cancer Society (IRG-116)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. https://app.cochat.ai/papers/10.1002/jbmr.5650101008
The paper
Hughes, D. E., Wright, K. R., Uy, H. L., Sasaki, A., Yoneda, T., Roodman, D. G., Mundy, G. R., & Dr. Boyce, B. F. (1995). Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. Journal of Bone and Mineral Research. https://doi.org/10.1002/jbmr.5650101008

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.